Citadel Advisors’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $504K | Sell |
152,156
-307,394
| -67% | -$1.02M | ﹤0.01% | 4053 |
|
2025
Q1 | $1.33M | Buy |
459,550
+77,872
| +20% | +$226K | ﹤0.01% | 2970 |
|
2024
Q4 | $1.36M | Sell |
381,678
-490,155
| -56% | -$1.74M | ﹤0.01% | 2997 |
|
2024
Q3 | $4.34M | Buy |
871,833
+704,020
| +420% | +$3.51M | ﹤0.01% | 1883 |
|
2024
Q2 | $436K | Sell |
167,813
-56,460
| -25% | -$147K | ﹤0.01% | 3921 |
|
2024
Q1 | $955K | Buy |
224,273
+56,456
| +34% | +$241K | ﹤0.01% | 3239 |
|
2023
Q4 | $339K | Buy |
167,817
+165,112
| +6,104% | +$334K | ﹤0.01% | 4120 |
|
2023
Q3 | $4.14K | Sell |
2,705
-582
| -18% | -$891 | ﹤0.01% | 5545 |
|
2023
Q2 | $5.42K | Buy |
+3,287
| New | +$5.42K | ﹤0.01% | 5450 |
|
2023
Q1 | – | Sell |
-2,910
| Closed | -$2.63K | – | 5894 |
|
2022
Q4 | $2.63K | Sell |
2,910
-15,153
| -84% | -$13.7K | ﹤0.01% | 5862 |
|
2022
Q3 | $21K | Sell |
18,063
-53,932
| -75% | -$62.7K | ﹤0.01% | 5523 |
|
2022
Q2 | $46K | Buy |
71,995
+35,205
| +96% | +$22.5K | ﹤0.01% | 5526 |
|
2022
Q1 | $96K | Sell |
36,790
-61,078
| -62% | -$159K | ﹤0.01% | 5671 |
|
2021
Q4 | $381K | Buy |
97,868
+56,157
| +135% | +$219K | ﹤0.01% | 4872 |
|
2021
Q3 | $182K | Buy |
+41,711
| New | +$182K | ﹤0.01% | 5488 |
|
2021
Q2 | – | Sell |
-75,463
| Closed | -$392K | – | 6378 |
|
2021
Q1 | $392K | Buy |
75,463
+51,209
| +211% | +$266K | ﹤0.01% | 4788 |
|
2020
Q4 | $130K | Sell |
24,254
-31,738
| -57% | -$170K | ﹤0.01% | 4620 |
|
2020
Q3 | $272K | Buy |
55,992
+29,765
| +113% | +$145K | ﹤0.01% | 3904 |
|
2020
Q2 | $127K | Buy |
26,227
+15,605
| +147% | +$75.6K | ﹤0.01% | 4196 |
|
2020
Q1 | $23K | Buy |
+10,622
| New | +$23K | ﹤0.01% | 4642 |
|
2018
Q4 | – | Sell |
-25,780
| Closed | -$451K | – | 4478 |
|
2018
Q3 | $451K | Buy |
+25,780
| New | +$451K | ﹤0.01% | 3224 |
|